Dipal Doshi, President and CEO at Entrada Therapeutics, Inc. (TRDA), sold 8,725 shares at $18.28 ($162K) on 2022-10-21, disclosed to the SEC on 2022-10-24.
Open-market sale of $162k TRDA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.01 | 811 | $15K | 9.0% |
| 2 | $18.28 | 2,786 | $51K | 31.5% |
| 3 | $18.28 | 2,786 | $51K | 31.5% |
| 4 | $18.90 | 1,101 | $21K | 12.9% |
| 5 | $19.65 | 1,241 | $24K | 15.1% |
| Total | $18.53 avg | 8,725 |
| $162K |
| 100% |
| Filing → |
| TRDA | SELL | 2024-05-20 | $45K | — | Filing → |
| TRDA | SELL | 2024-02-20 | $15K | — | Filing → |
| TRDA | SELL | 2024-01-18 | $16K | — | Filing → |